RE:RE:what's going on? Great Call.
2014-03-28 16:58 ET - News Release
Mr. Anthony Giovinazzo reports
CYNAPSUS THERAPEUTICS FILES PRELIMINARY SHORT FORM PROSPECTUS
Cynapsus Therapeutics Inc. has filed a preliminary short-form prospectus with the securities regulatory authorities in the provinces of British Columbia, Alberta and Ontario, in connection with a best-efforts offering of common shares and warrants of Cynapsus for gross proceeds of $15-million to $25-million. Final pricing and determination of the number of common shares and warrants to be sold pursuant to the offering will occur immediately prior to the filing of the final short-form prospectus in respect of the offering.
The company has retained M Partners Inc. to lead the offering. An agency agreement for the offering will be entered into by the company and the agent.
Closing of the offering is subject to final pricing and TSX Venture Exchange approval. The net proceeds of the offering will be used to finance research and development activities for the company's APL-130277 Parkinson's disease drug candidate, and for general working capital purposes. The first closing of the offering is expected to occur on or about April 18, 2014